Asahi's high flux polysulfone membrane specially developed for CRRT with:
High permeability and sharp cut-off curve
Superior biocompatibility
Low albumin loss
Long filter life
Cureflo is intended for patients with renal failure who also suffer from severe complications, such as multiple organ failure or cardiac and circulatory problems, including cardiac insufficiency and edema, who are not adequately treated by intermittent dialysis therapy. Cureflo is used to correct and purify body fluid through continuous hemofiltration (normally in excess of 10 hrs.).
Microporous gradient structure (dense and homogenous inside surface and porous outside area) provides "High permeability" and "Sharp cut-off" features.
The change of WBC, C3a and granulocyte elastase is very small during treatment.
Specification | ACF-130W | ACF-180W | |
---|---|---|---|
Hollow Fiber | Material | Polysulfone | |
Inside Diameter | 200 μm | ||
Wall Thickness | 45 μm | ||
Effective Surface Area | 1.3 m2 | 1.8 m2 | |
Priming Volume | 80 mL | 108 mL | |
Max. TMP | 66 kPa (500 mmHg) | ||
Sterilization | Gamma-Ray |
Specification | ACF-110W | |
---|---|---|
Hollow Fiber | Material | Polysulfone |
Inside Diameter | 200 μm | |
Wall Thickness | 45 μm | |
Effective Surface Area | 1.1 m2 | |
Priming Volume | 66 mL | |
Max. TMP | 66 kPa (500 mmHg) | |
Sterilization | Gamma-Ray |